Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 706,848 shares changed hands during mid-day trading, an increase of 16% from the previous session's volume of 609,186 shares.The stock last traded at $15.34 and had previously closed at $15.40.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd.
Get Our Latest Stock Report on AVNS
Avanos Medical Stock Performance
The firm has a market cap of $701.76 million, a price-to-earnings ratio of 44.91 and a beta of 0.99. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a 50 day moving average of $17.91 and a 200 day moving average of $20.93.
Hedge Funds Weigh In On Avanos Medical
Several large investors have recently modified their holdings of AVNS. JPMorgan Chase & Co. boosted its holdings in Avanos Medical by 6.9% in the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock worth $1,672,000 after purchasing an additional 4,472 shares during the period. Geode Capital Management LLC lifted its position in shares of Avanos Medical by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company's stock worth $25,337,000 after buying an additional 16,065 shares during the last quarter. Barclays PLC boosted its holdings in shares of Avanos Medical by 446.2% in the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after buying an additional 78,583 shares during the period. Zacks Investment Management bought a new stake in shares of Avanos Medical during the 3rd quarter valued at about $335,000. Finally, EP Wealth Advisors LLC acquired a new stake in Avanos Medical during the third quarter worth about $212,000. Institutional investors own 95.17% of the company's stock.
Avanos Medical Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
